Citations

Showing 10 of 108104 citations.

Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1
Jung, M. Katherine , Aibaidula, Abudumijiti, Garcia, Luz Milbeth Cumba, Parney, Ian F. , Jung, Mi-Yeon, Brown, Desmond A., Himes, Benjamin T., Cumba Garcia, Luz M, Parney, Ian F , Brown, Desmond , Himes, Benjamin

Mayo Clinic

Neuro-Oncology Advances | February 15, 2022 | Volume: 4 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdac017 | PMID 35990703 Get It

Abstract Background Glioblastoma (GBM), the most common primary brain tumor, has a median survival of 15–16 months. Immunotherapy is promising but GBM-mediated immunosuppression remains a barrier. GBMs express the interferon-gamma (IFN-γ)-responsive immunosuppressive molecules programmed cell death ligand 1 (PD-L1) and indoleamine 2,3-dioxygenase 1 (IDO1). Extracellular vesicles (EVs) have also been implicated in GBM-mediated immunosuppression, in part through PD-L1. We therefore sought to determine if GBM IFN-γ exposure increased GBM EV-mediated immunosuppression and mechanisms underlying this. Methods Human GBM-derived cells were cultured in the presence/absence of IFN-γ. EVs were harvested. PD-L1, IDO1, and EV-associated protein expression was assessed. GBM EVs (+/−IFN-γ) were cultured with healthy donor monocytes. Immunosuppressive myeloid-derived suppressor cell (MDSC) and nonclassical monocyte (NCM) frequency was determined. Impact of GBM (+/−IFN-γ) EV-treated monocytes on CD3/CD28-mediated T cell proliferation was assessed. The impact of PD-L1 and IDO1 knockdown in GBM EVs in this system was evaluated. Results IFN-γ exposure increased PD-L1 and IDO1 expression in GBM cells and EVs without altering EV size or frequency. IFN-γ-exposed GBM EVs induced more MDSC and NCM differentiation in monocytes and these monocytes caused more T cell inhibition than IFN-γ-naive GBM EVs. PD-L1 and/or IDO1 knockdown in GBM cells abrogated the immunosuppressive effects of IFN-γ-exposed GBM EVs on monocytes. Conclusions IFN-γ exposure such as might occur during an antitumor immune response results in superinduction of GBM EVs’ baseline immunosuppressive effects on monocytes. These effects are mediated by increased PD-L1 and IDO1 expression in GBM EVs. These data highlight mechanisms of GBM EV-mediated immunosuppression and identify therapeutic targets (PD-L1, IDO1) to reverse these effects.
Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation
Nakajima, Atsushi , Ishizaki, Sonoko, Kurosu, Shinsuke , Taniguchi, Shinya , Gillberg, Per‐Göran , Mattsson, Jan P. , Hasunuma, Tomoko , Camilleri, Michael , Camilleri, M , Nakajima, Atsushi , Matsuda, Kazuki Mitsuru

Mayo Clinic

Journal of Gastroenterology and Hepatology | February 15, 2022 | Volume: 37 | Issue: 5 | Pages: 883-890

10.1111/jgh.15800 | PMID 35168298 Get It

Abstract Background and Aim Elobixibat is a locally acting inhibitor of the ileal bile acid transporter. We compared bile acid metabolism between healthy subjects and patients with chronic constipation and assessed changes in the bile acid profile after elobixibat administration in the latter group. Methods Healthy subjects ( n = 10) and patients with chronic constipation ( n = 19) were assessed as inpatients for 7 days, during which they received meals containing ~60 g/day of fat. Patients with chronic constipation remained as inpatients for a further 7 days for once‐daily elobixibat administration. Assessments included concentrations of fecal and serum bile acids, serum 7α‐hydroxy‐4‐cholesten‐3‐one (C4) and fibroblast growth factor 19, and bowel movements and constipation symptoms. Results Fecal total and primary bile acids were significantly lower in patients with chronic constipation versus healthy subjects. Serum C4 and fibroblast growth factor 19 levels were comparable between groups. Elobixibat treatment increased fecal total and primary bile acids and decreased levels of fecal lithocholic acid and serum total as well as secondary bile acids in patients with chronic constipation. Bowel movements and other constipation‐related symptoms were also improved by elobixibat to levels almost comparable with those of healthy subjects. Conclusions Despite comparable C4 levels, patients with chronic constipation demonstrated decreased levels of fecal bile acids versus healthy subjects. Elobixibat treatment increased fecal bile acid excretion and reduced serum bile acid concentrations. The improvement of constipation after elobixibat treatment was associated with increased total bile acids, particularly primary bile acids.
The North American opioid epidemic: opportunities and challenges for clinical laboratories
Delaney, Sarah , Tacker, Danyel H. , Snozek, Christine L.H. , Delaney, Sarah R.

Mayo Clinic

Critical Reviews in Clinical Laboratory Sciences | February 15, 2022 | Volume: 59 | Issue: 5 | Pages: 309-331

10.1080/10408363.2022.2037122 | PMID 35166639 Get It

Accuracy of Simulated Research Tasks by Community Hospitals Participating in a Multicenter Telemedicine Trial
Fang, Jennifer L. , Whyte, Hilary, Umoren, Rachel , Limjoco, Jamie , Yankanah, Rosanna, McCoy, Mike, Lo, Mark D., Demaerschalk, Bart M. , Demaerschalk, Bart M , Makkar, Abhishek , Herrin, Jeph

Mayo Clinic

Telemedicine and e-Health | February 15, 2022 | Volume: 28 | Issue: 10 | Pages: 1489-1495

10.1089/tmj.2021.0574 | PMID 35167373 Get It

Background/Aims: Clinical trials evaluating facility-to-facility telemedicine may include sites that have limited research experience. For the trial to be successful, these sites must correctly perform research-related tasks. This study aimed to determine whether health care professionals at community hospitals could accurately identify simulated study eligible patients and submit data to a research coordinating center. Methods: Twenty-seven community hospitals in the United States and Canada participated in this study. An electronic survey was sent to one designated health care professional at each site. The survey included a description of trial eligibility criteria and five written neonatal resuscitation scenarios. For each scenario, the participant determined whether the neonate was study eligible. One scenario required participants to submit 14 data elements to the coordinating center. Accuracy of study eligibility and data submission was summarized using standard descriptive statistics. Results: The survey response rate was 100% (27/27). Overall accuracy in determining study eligibility was 89% (120/135), and accuracy varied across the five scenarios (range 82–93%). Overall accuracy of data submission was 92% (310/336). Data were >95% accurate for 9 of the 14 data elements, with 100% accuracy achieved for 6 data elements. These results were used to clarify eligibility criteria, inform database design, and improve training materials for the subsequent clinical trial. Conclusions: Health care professionals at community hospitals accurately determined trial eligibility and submitted study data based on written clinical scenarios. Research teams conducting telemedicine trials with community hospitals should consider completing pre-trial simulation activities to identify opportunities for improving trial processes and materials.
Gross Extrathyroidal Extension into Strap Muscles and Disease-Specific Mortality in Papillary Thyroid Cancer
Lincango-Naranjo, Eddy , Brito, Juan P.

Mayo Clinic

Clinical Thyroidology | February 15, 2022 | Volume: 34 | Issue: 2 | Pages: 78-80

10.1089/ct.2022;34.78-80 Get It

Guiding the global evolution of cytogenetic testing for hematologic malignancies
Akkari, Yassmine, Baughn, Linda B. , Dubuc, Adrian M. , Smith, Adam C. , Mallo, Mar , Cin, Paola Dal , Díez‐Campelo, María , Gallego, Marta S., Granada, Isabel , Haase, D., Schlegelberger, Brigitte , Slavutsky, Irma , Mecucci, Cristina , Levine, Ross L. , Hasserjian, Robert P. , Solé, Françesc , Levy, Brynn , Xu, Xinjie , Akkari, Yassmine M N , Dal Cin, Paola , Granada Font, Isabel , Baughn, Linda B , Solé, Francesc , Diez-Campelo, Maria , Haase, Detlef

Mayo Clinic

Blood | February 15, 2022 | Volume: 139 | Issue: 15 | Pages: 2273-2284

10.1182/blood.2021014309 | PMID 35167654 Get It

Abstract Cytogenetics has long represented a critical component in the clinical evaluation of hematologic malignancies. Chromosome banding studies provide a simultaneous snapshot of genome-wide copy number and structural variation, which have been shown to drive tumorigenesis, define diseases, and guide treatment. Technological innovations in sequencing have ushered in our present-day clinical genomics era. With recent publications highlighting novel sequencing technologies as alternatives to conventional cytogenetic approaches, we, an international consortium of laboratory geneticists, pathologists, and oncologists, describe herein the advantages and limitations of both conventional chromosome banding and novel sequencing technologies and share our considerations on crucial next steps to implement these novel technologies in the global clinical setting for a more accurate cytogenetic evaluation, which may provide improved diagnosis and treatment management. Considering the clinical, logistic, technical, and financial implications, we provide points to consider for the global evolution of cytogenetic testing.
Radial artery diameter: a comprehensive systematic review of anatomy
Wahood, Waseem , Ghozy, Sherief , Al-Abdulghani, Abdulaziz, Kallmes, David F. , Ghozy, Sherief

Mayo Clinic

Journal of NeuroInterventional Surgery | February 15, 2022 | Volume: 14 | Issue: 12 | Pages: 1274-1278

10.1136/neurintsurg-2021-018534 | PMID 35169033 Get It

Aims The objective of this systematic review is to determine with the highest accuracy the average radial artery (RA) diameter overall and in certain subgroups. The aim of this study is to provide assistance in the development of fitting transradial devices, an increasingly popular intervention. Methods Several databases were used to extract appropriate studies highlighting RA diameter. Databases used in the generation of this study were Ovid EBM Reviews, Ovid Embase, Ovid Medline, Scopus and Web of Science Core Collection. RA diameter was determined overall, in males versus females, adults only, adults+children, in the presence of comorbidities, and finally RA diameter in the context of various vasodilators. Results A total of 71 studies were included. The average RA diameter overall was determined to be 2.62±0.15 mm in children+adults and 2.70±0.15 mm in adults only. In comparison to an RA diameter of 2.68±0.24 mm in adult males, the diameter was found to be 2.27±0.27 mm in adult females (p=0.028). As for comorbidities, the mean RA diameter in adult patients with hypertension and congestive heart failure was 2.72±0.37 mm and 2.80±0.25 mm, respectively. Finally, the mean RA diameter with nitrate and angiotensin-converting enzyme (ACE) inhibitor use was 2.97±0.53 mm and 2.82±0.29 mm respectively. For comparison, the average outer diameter of a 5 French introducer sheath is 2.29 mm and a 6 French introducer sheath is 2.62 mm. Conclusions The findings presented in this study will help determine the most appropriate transradial device to use in several different populations in the context of vasodilator usage or the absence thereof.
How to build a successful hypertrophic cardiomyopathy team and ensure training the next generation of myectomy surgeons
Oberoi, Meher , Oberoi, Meher , Schaff, Hartzell V. , Dearani, Joseph A.

Mayo Clinic

Asian Cardiovascular and Thoracic Annals | February 15, 2022 | Volume: 30 | Issue: 1 | Pages: 19-27

10.1177/02184923211053399 | PMID 35167375 Get It

Transaortic extended septal myectomy is the most reliable method for septal reduction for symptomatic patients with obstructive hypertrophic cardiomyopathy. In addition, surgical management of nonobstructive hypertrophic cardiomyopathy is possible for selected patients with diastolic heart failure and small left ventricular end-diastolic cavity dimensions. These procedures, however, are performed infrequently in many centers, and trainees may not be exposed to the preoperative evaluation and intraoperative management of patients with hypertrophic cardiomyopathy. In this paper, we review what we believe are the central features for creating a successful program for septal myectomy and detail our strategies to optimize instruction in these techniques for residents and fellows.
Allergic conditions and risk of rheumatoid arthritis: a Swedish case–control study
Kronzer, Vanessa L. , Westerlind, Helga , Crowson, Cynthia S. , Klareskog, Lars , Holmqvist, Marie , Askling, Johan , Crowson, CS , Klareskog, Lars , Holmqvist, Marie , Askling, Johan , Kronzer, Vanessa L , Alfredsson, Lars

Mayo Clinic

RMD Open | February 15, 2022 | Volume: 8 | Issue: 1 | Pages: e002018

10.1136/rmdopen-2021-002018 | PMID 35168998 Get It

Objective To determine the association of allergic conditions with incident rheumatoid arthritis (RA), especially in relation to smoking history and anti-citrullinated peptide antibody (ACPA) status. Methods This case–control study included 3515 incident RA cases and 5429 matched controls from the Epidemiological Investigation of Rheumatoid Arthritis study 1995 to 2016, including questionnaire-based information on eight allergic conditions composed from a list of 59 unique allergies. We used logistic regression and adjusted ORs (aOR) to assess the association between allergic conditions and risk of RA, adjusting for age, sex, residential area, body mass index, education, and smoking, and stratified by smoking and ACPA. Results A history of any reported allergy was equally common in RA (n=1047, 30%) as among population controls (n=1540, 29%), aOR 1.04, 95% CI 0.95 to 1.15. Metal, respiratory, food, plant/pollen and chemical allergies were not associated with risk of RA. By contrast, statistically significant associations were observed for animal dander allergy (6% vs 5%, aOR 1.37, 95% CI 1.03 to 1.82), especially in ACPA-positive RA (aOR 1.46 95% CI 1.06 to 2.01) and for atopic dermatitis, in particular for older and ACPA-negative RA (aOR 2.33, 95% CI 1.37 to 3.96 at age 80). Never smokers with allergic rhinitis also had increased risk of developing RA (aOR 1.30, 95% CI 1.00 to 1.68). Conclusion Most common allergies do not increase risk of RA, nor do they protect against RA. However, some allergic conditions, notably animal dander allergy, atopic dermatitis and allergic rhinitis, were associated with an increased risk for RA.
Transcriptional analysis of lung fibroblasts identifies PIM1 signaling as a driver of aging-associated persistent fibrosis
Pham, Tho X., Lee, Jisu , Guan, Jiazhen, Caporarello, Nunzia , Meridew, Jeffrey A., Jones, Dakota L. , Huang, Steven K. , Tschumperlin, Daniel J. , Ligresti, Giovanni , Caporarello, Nunzia , Tan, Qi

Mayo Clinic

JCI Insight | February 15, 2022 | Volume: 7 | Issue: 6 | Pages: No page available

10.1172/jci.insight.153672 | PMID 35167499 Get It

Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease characterized by myofibroblast accumulation and progressive lung scarring. To identify transcriptional gene programs driving persistent lung fibrosis in aging, we performed RNA-Seq on lung fibroblasts isolated from young and aged mice during the early resolution phase after bleomycin injury. We discovered that, relative to injured young fibroblasts, injured aged fibroblasts exhibited a profibrotic state characterized by elevated expression of genes implicated in inflammation, matrix remodeling, and cell survival. We identified the proviral integration site for Moloney murine leukemia virus 1 (PIM1) and its target nuclear factor of activated T cells-1 (NFATc1) as putative drivers of the sustained profibrotic gene signatures in injured aged fibroblasts. PIM1 and NFATc1 transcripts were enriched in a pathogenic fibroblast population recently discovered in IPF lungs, and their protein expression was abundant in fibroblastic foci. Overexpression of PIM1 in normal human lung fibroblasts potentiated their fibrogenic activation, and this effect was attenuated by NFATc1 inhibition. Pharmacological inhibition of PIM1 attenuated IPF fibroblast activation and sensitized them to apoptotic stimuli. Interruption of PIM1 signaling in IPF lung explants ex vivo inhibited prosurvival gene expression and collagen secretion, suggesting that targeting this pathway may represent a therapeutic strategy to block IPF progression.